Posts Tagged ‘sichenzia ross friedman ference’
Sichenzia Ross Friedman Ference LLP Represents General Cannabis Corp. in $2.6 million Private Offering of Senior Secured Notes and Warrants
General Cannabis Corp.
$2,600,000
Senior Secured Promissory Notes
Common Stock Purchase Warrants
September 2016
Read MoreSichenzia Ross Friedman Ference LLP Represents SITO MOBILE, Ltd. in $11.5 Million Public Offering
Sichenzia Ross Friedman Ference LLP Represents Rodman & Renshaw as Exclusive Placement Agent for a $5 Million Registered Direct Offering
CEL-SCI Corporation
$5,000,000
Registered Direct Offering of Common Stock
Private Placement of Warrants
Represented Rodman & Renshaw, a unit of H.C. Wainwright& Co., LLC, as Exclusive Placement Agent
August 2016
Read MoreSichenzia Ross Friedman Ference LLP Represents Aridis Pharmaceuticals in $15 Million Private Placement
Aridis Pharmaceuticals, Inc.
$15,200,000
Private Placement of Common Stock and Warrants
August 2016
Read MoreSichenzia Ross Friedman Ference LLP Represents Vuzix Corporation in $6.6 Million Public Offering
Partners Marc J. Ross and James M. Turner Represent Tonix Pharmaceuticals in $10 Million Public Offering of Common Stock
Sichenzia Ross Friedman Ference LLP Represents Joseph Gunnar in $2.1 Million Public Offering of Intellicheck Mobilisa, Inc.
Intellicheck Mobilisa, Inc.
$2,100,000
Public Offering
Common Stock and Warrants
Represented Joseph Gunnar & Co. LLC as Sole Book-Running Manager
June 2016
Read MoreSichenzia Ross Friedman Ference LLP Represents Joseph Gunnar and Fordham Financial Management in $7.5 Million Public Offering of Aytu Bioscience, Inc.
Aytu BioScience, Inc. .
$7,500,000
Public Offering
Common Stock and Warrants
Represented Joseph Gunnar and Fordham Financial Management, Inc. as Lead Manager
May 2016
Read MoreSichenzia Ross Friedman Ference LLP Represents Citius Pharmaceuticals Inc. in connection with its acquisition of LM Biosciences, Inc.
Sichenzia Ross Friedman Ference LLP Represents H.C. Wainwright & Co., LLC and Joseph Gunnar & Co., LLC as Joint Book Running Managers for $6.0 Public Offering and Uplisting to Nasdaq
